| Nov 13 |
Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3
|
| Nov 7 |
Q3 2024 Certara Inc Earnings Call
|
| Nov 7 |
Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
| Nov 7 |
Certara, Inc. (CERT) Q3 2024 Earnings Conference Call Transcript
|
| Nov 7 |
Certara, Inc. (CERT) Q3 Earnings Surpass Estimates
|
| Nov 6 |
Certara Non-GAAP EPS of $0.13 beats by $0.02, revenue of $94.8M misses by $0.77M
|
| Nov 6 |
Certara Reports Third Quarter 2024 Financial Results
|
| Nov 5 |
Certara Q3 2024 Earnings Preview
|
| Oct 27 |
Certara, Inc. (NASDAQ:CERT) Shares Could Be 23% Above Their Intrinsic Value Estimate
|
| Oct 16 |
Certara Appoints John Reynders as New Independent Board Member
|
